MPG.eBooks - Search Results - Organization

Cover Image

1

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

“... Health Organization (WHO) functional class (FC) II to III to delay disease progression...”

Cover Image

2

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension

Published 2016

Canadian Agency for Drugs and Technologies in Health

“... Health Organization (WHO) functional class (FC) II to III to delay disease progression...”